Home Novel Bi- and Trifunctional Inhibitors of Tumor-Associated Proteolytic Systems
Article
Licensed
Unlicensed Requires Authentication

Novel Bi- and Trifunctional Inhibitors of Tumor-Associated Proteolytic Systems

  • J. Krol , S. Sato , P. Rettenberger , I. Assfalg-Machleidt , M. Schmitt , V. Magdolen and U. Magdolen
Published/Copyright: June 1, 2005
Biological Chemistry
From the journal Volume 384 Issue 7

Abstract

Serine proteases, cysteine proteases, and matrix metalloproteinases (MMPs) are involved in cancer cell invasion and metastasis. Recently, a recombinant bifunctional inhibitor (chCys-uPA19-31) directed against cysteine proteases and the urokinase-type plasminogen activator (uPA)/plasmin serine protease system was generated by introducing the uPA receptor (uPAR)-binding site of uPA into chicken cystatin (chCysWT). In the present study, we designed and recombinantly produced multifunctional inhibitors also targeting MMPs. The inhibitors comprise the Nterminal inhibitory domain of human TIMP-1 (tissue inhibitor of matrix metalloproteinase-1) or TIMP-3, fused to chCys-uPA19-31 or chCysWT. As demonstrated by various techniques, these fusion proteins effectively interfere with all three targeted protease systems. In in vitro Matrigel invasion assays, the addition of recombinant inhibitors strongly reduced invasion of ovarian cancer cells (OV-MZ-6#8). Additionally, OV-MZ 6#8 cells were stably transfected with expression plasmids encoding the various inhibitors. Synthesis and secretion of the inhibitors was verified by a newly developed ELISA, which selectively detects the recombinant proteins. Invasive capacity of inhibitorproducing cells was significantly reduced compared to vector-transfected control cells. Thus, these novel, compact, and small-size inhibitors directed against up to three different tumor-associated proteolytic systems may represent promising agents for prevention of tumor cell migration and metastasis.

:
Published Online: 2005-06-01
Published in Print: 2003-07-15

Copyright © 2003 by Walter de Gruyter GmbH & Co. KG

Downloaded on 24.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/BC.2003.121/html
Scroll to top button